Prostrakan Share Discussion Threads

[craigends] 20/1/2010 15:43

This steady rise -with some reasonable volumes continues, is this a trend 'till March 18th results? Have been optimistic holder since the 60p level on basis turnround must come soon or it will be acquired.

[phil140158] 07/1/2010 19:46

Aspers, I saw the trading statement RNS at 07.00, kitchen too b....y cold to linger for long, so I didn't read it! Could have got in cheap after it fell around 09.00. Great opportunity missed. Good luck to all and PSK.

[grimraider] 07/1/2010 16:58

Couldnt see, but was exchange rate impact removed or included in trading statement?

[the_doctor] 07/1/2010 16:39

I was really only looking for a trade and still think the co. isnt cheap.
Good luck all the same though.

[the_doctor] 07/1/2010 11:17

Agreed. I thought of buying at 9:30 when I got in, but got distracted.

I've been bearish, but this update is encouraging.

[jdung] 07/1/2010 08:08

good news today ,

[the_doctor] 16/12/2009 09:49

Trouble is, the market cap is still £200m when you factor in the debt.

The pipeline is also pretty weak looking forward.

While I dont mean to sound bearish, the company will start to struggle if any of its recent/pending launches underperform.
Similarly, they've got to get Fortigel approved in the US.

[farmsted] 15/12/2009 16:23

Hi.Bought at 105 in november and will need to average down when the price gets below 80p, this time next week.

[the_doctor] 11/12/2009 16:10

Nope
But if large trades continue from the same person, you may get a holdings announcement.

I've been thinking if I'd invest here.
With the amount of debt they've got, it does put me off buying at any price around here.
However, if it gets to 80p I'll consider a punt

[craigends] 11/12/2009 15:52

Trades have been dominated over last few days with large tranches e.g today 650000.
Anyone know who has made these or where to find out? thanks

[grimraider] 25/11/2009 19:10

Yes, but am still kicking myself that I didnt buy in when it was in the 50 range, still not sure why the sudden increase

[the_doctor] 25/11/2009 19:00

Yes, Cephalon is the primary competitor, but I forget how they're positioned in Europe. Similarly with generic patches.

The testosterone gel does offer more advantages than I first thought, but they have to get it approved of course.
A lot has changed with that delay

In general I'm also of the view that the portfolio isnt too exciting. They'll need to bulk it up and that'll drain what money they make after the debt is paid off.

[grimraider] 25/11/2009 18:51

the doctor

Yes, I believe switching to their own but at 1/3rd reduction in size and I believe refocusing field force on larger cities/population centres. Additional concern is increasing competiton from Cephalon (more aggressive) in UK and possible Europe to Abstral - breakthrough pain. Looking increasingly like the product portfolio lacks luster and is more like high price generic than nich. I am holding back, as feel overpriced even at 100p. Will wait to see how cost control/profitability is achieved in an increasingly price sensitive market

[the_doctor] 25/11/2009 12:20

Grim - are they not switching from NovaQuest to their own?

Sub 100p, but although I considered it, I'm not tempted. Market cap still ~£200m
Poor numpties that were buying at 150p. I'm at a total loss to know why they were??

[grimraider] 20/11/2009 08:45

Interestingly, no mention of the reduction in the size of the US field force, is this a move to reduce cost?

[the_doctor] 19/11/2009 15:17

Is it notable that they no longer mentioned profitability in the IMS?
(I only flicked through)

[ricartonl] 19/11/2009 15:00

Hasn't quite reached a £1.

Was looking to buy a couple of thousand of these.

[the_doctor] 04/11/2009 12:33

..... going by pre-deal broker notes and adjusting, it would seem that the expectation is for PSK to be ok in terms of paying down debt despite the US delays.

However, longer-term implications depend on what they have to now do to get approval.

Most of the near-term catalysts have now passed, so my expectation is this will trade with the market and/or down without news.
I'd consider buying below 90p depending on cash availability.

[the_doctor] 22/10/2009 18:29

farmsted

Havent had time to go over the debt repayment schedule I'm afraid

Looks like most of the near-term catalysts are now gone (from memory), so I'm expecting a period of weakness.

As an interim answer, I'll look back at the broker notes and see how things changed

[typo56] 21/10/2009 07:27

ProStrakan Group cut to neutral from outperform by Credit Suisse

[farmsted] 20/10/2009 11:35

Thanks doc I look forward to hearing from you on the debt. could be a buyer at 100.

[grimraider] 19/10/2009 17:45

Looks like more problems ahead as a direct competitor in break through pain launched plus a nasal version as well, may also impact on sales growth further delaying profitability

[the_doctor] 19/10/2009 15:00

.......I did wonder if this might happen, after the issues before and the FDA's general caution with hormonal treatments.

So, that's delayed the milestones from this by a year.

Profitability could now also be delayed - or come then go again.

So, what does that mean in terms of them paying off their debt?

I'm not so sure myself. Will have to look into it.

[farmsted] 19/10/2009 14:41

I think your right doctor it will soon be `100p